Potent and selctive compounds as serotonin 1b receptor modulators

The present invention relates to new compounds of formula (I):as modulators of serotonin receptor 1B (5-HTR1B) also known as 5-hydroxytryptamine receptor 1B (5-HT1B). The compounds are of potential utility in the treatment of diseases and conditions mediated by serotonin receptor type 1B (5-HTR1B),...

Full description

Saved in:
Bibliographic Details
Main Authors CLEMENT-DEMANGE Lise, CASTRO- PALOMINO LARIA Julio, MUNOZ RISUENO Ruth, CAMACHO GOMEZ Juan Alberto
Format Patent
LanguageEnglish
Hebrew
Published 01.05.2023
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to new compounds of formula (I):as modulators of serotonin receptor 1B (5-HTR1B) also known as 5-hydroxytryptamine receptor 1B (5-HT1B). The compounds are of potential utility in the treatment of diseases and conditions mediated by serotonin receptor type 1B (5-HTR1B), such as cancer, including blood cancer and solid tumors, respiratory diseases and hepatic disorders.
Bibliography:Application Number: IL20230301806